Mayram Koshukeeva, Acting Associate Professor of the Department of Pediatrics and Allergist-Immunologist at the International Higher School of Medicine (IHSM), participated in the European Academy of Allergy and Clinical Immunology Congress (EAACI Congress 2026) held from June 11 to 15, 2026, in Istanbul, Türkiye.
EAACI Congress is one of the world's leading scientific events in the field of allergy and clinical immunology, bringing together leading clinicians, researchers, and scientists from across the globe. In 2026, the congress welcomed approximately 8,000 delegates from numerous countries.
As part of the scientific programme, Mayram Koshukeeva presented the results of her research through two poster presentations focusing on current issues in pediatric allergy. The presented studies attracted considerable interest from the international scientific community and provided an opportunity for professional exchange with specialists from different countries.
The congress programme included plenary lectures, scientific symposia, educational sessions, and workshops dedicated to the latest advances in the diagnosis, treatment, and prevention of allergic and immunological diseases. Particular attention was given to allergen-specific immunotherapy, molecular allergology, bronchial asthma, atopic dermatitis, and food allergy.
Participation in EAACI Congress 2026 reflects IHSM's commitment to advancing scientific research, strengthening international academic cooperation, and integrating evidence-based approaches into medical education and clinical practice.
EAACI Congress is one of the world's leading scientific events in the field of allergy and clinical immunology, bringing together leading clinicians, researchers, and scientists from across the globe. In 2026, the congress welcomed approximately 8,000 delegates from numerous countries.
As part of the scientific programme, Mayram Koshukeeva presented the results of her research through two poster presentations focusing on current issues in pediatric allergy. The presented studies attracted considerable interest from the international scientific community and provided an opportunity for professional exchange with specialists from different countries.
The congress programme included plenary lectures, scientific symposia, educational sessions, and workshops dedicated to the latest advances in the diagnosis, treatment, and prevention of allergic and immunological diseases. Particular attention was given to allergen-specific immunotherapy, molecular allergology, bronchial asthma, atopic dermatitis, and food allergy.
Participation in EAACI Congress 2026 reflects IHSM's commitment to advancing scientific research, strengthening international academic cooperation, and integrating evidence-based approaches into medical education and clinical practice.